Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126241081 | 12624108 | 1 | I | 201605 | 20160711 | 20160805 | 20160805 | PER | US-ASTRAZENECA-2016SE77567 | ASTRAZENECA | 907.00 | MON | M | Y | 86.20000 | KG | 20160805 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126241081 | 12624108 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | DAILY | U | U | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||
| 126241081 | 12624108 | 2 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 0 | 2 | MG | /wk | ||||||||
| 126241081 | 12624108 | 3 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 126241081 | 12624108 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 1000 | MG | Q12H | ||||||||
| 126241081 | 12624108 | 5 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 126241081 | 12624108 | 6 | C | COREG | CARVEDILOL | 1 | Oral | 0 | 3.125 | MG | QD | ||||||||
| 126241081 | 12624108 | 7 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 300 | MG | QD | ||||||||
| 126241081 | 12624108 | 8 | C | THYROID | LEVOTHYROXINELIOTHYRONINE | 1 | Oral | 0 | 60 | MG | QD | ||||||||
| 126241081 | 12624108 | 9 | C | ZETIA | EZETIMIBE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126241081 | 12624108 | 10 | C | B6 | PYRIDOXINE HYDROCHLORIDE | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 126241081 | 12624108 | 11 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 0 | 500 | MG | QD | ||||||||
| 126241081 | 12624108 | 12 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126241081 | 12624108 | 13 | C | PROBIOTIC | PROBIOTICS NOS | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126241081 | 12624108 | 14 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 0 | 300 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126241081 | 12624108 | 1 | Type 2 diabetes mellitus |
| 126241081 | 12624108 | 2 | Type 2 diabetes mellitus |
| 126241081 | 12624108 | 4 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126241081 | 12624108 | Blood pressure fluctuation | |
| 126241081 | 12624108 | Cataract | |
| 126241081 | 12624108 | Gastrooesophageal reflux disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126241081 | 12624108 | 1 | 2014 | 201606 | 0 | |
| 126241081 | 12624108 | 2 | 20160627 | 0 |